Pricing Log in Create free account

Jupiter Neurosciences, Inc. (JUNS) vs NuCana PLC Sponsored ADR (NCNA)

Jupiter Neurosciences, Inc. and NuCana PLC Sponsored ADR are both Biotechnology companies. Jupiter Neurosciences, Inc. and NuCana PLC Sponsored ADR are of similar size ($4.4M and $4.1M). Across the 8 metrics below, Jupiter Neurosciences, Inc. leads on 4 and NuCana PLC Sponsored ADR on 4.

Valuation

Metric JUNS NCNA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 0.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.45 0.64
EV/Sales n/m n/m 9.21
Earnings yield (656.97%) (226,311.31%) (33.15%)
Free cash flow yield (446.77%) (170,262.15%) (25.50%)

Profitability

Metric JUNS NCNA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,888.80%) (68.70%) (56.36%)
Return on assets (239.36%) (45.24%) (48.04%)
Return on invested capital 0.00% (1,130.23%) 0.00%

Growth

Metric JUNS NCNA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (212.50%) 98.96% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric JUNS NCNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.66 4.73 4.72
Net debt to EBITDA 0.43 1.23 0.96

Dividend

Metric JUNS NCNA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric JUNS NCNA Biotechnology median
Market cap 4.14m 4.40m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack